Seoul biotech’s redesigned method makes circular RNA up to seven times more efficient to build, widening what RNA medicine can treat.

NKGen presented new clinical data on troculeucel’s potential in Alzheimer’s, Parkinson’s and frontotemporal dementia.

Longevity brand launches a spray tech that skips gut entirely, betting that how a supplement is delivered matters as much as what’s in it.

With one in five citizens now 65 or older, Taiwan’s largest healthy-aging expo argued that older adults are a workforce to ...

Our new Longevity Biotech Report puts a number on longevity's payoff – and asks who actually gets to cash it in.

LOY-003, a daily tablet for large and giant breeds, has earned RXE acceptance, the third such milestone for a Loyal lifespan ...

The first patient has been dosed in a Phase 2 trial of BGE-102, an oral pill built on human aging research, aimed at preserving vision.

New US patent covers fibroblast-based treatment for wounds that won't close – increasingly common, and risky, with age.

Open benchmark tests whether AI can reason across aging biology – and finds specialist models can outperform far larger systems.

Trial of 8,000+ people finds cardiovascular drug fails to cut heart attacks and strokes, leaving a key longevity risk unresolved. The drug pelacarsen did exactly what it was supposed to do, chemically ...

A biotech partnership is using AI to hunt for a drug that protects muscle from the very treatments meant to help people lose weight.